With the good news recently regarding the Pfizer and Moderna vaccines, I remain concerned about COVID-19 vaccine manufacturing bottlenecks. This could be an important issue that seems to be ignored by a lot of the public. This isn’t some MBA school consideration, it is a serious problem that could delay these vaccines for a long time.
I constantly joke that people oversimplify how we get a vaccine – throw some ingredients in a blender and, voila, we’ve got a vaccine. If only it was that easy.
This article is going to attempt to review COVID-19 vaccine manufacturing along with some of the bottlenecks that keep appearing. And this isn’t just an issue with the two mRNA vaccines that seem to be the fastest to market, but with all of the leading vaccines.